Virpax Pharmaceuticals prices $40M public stock offering
September 15, 2021 at 13:22 PM EDT
The company plans to use the proceeds to advance its non-opioid and non-addictive pain management products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.